Do ACE rs4343 GG and ADD1 rs4961 GT genotypes increase salt sensitivity and RAAS-driven blood pressure tendency?

Genetic evidence suggests that specific polymorphisms in the ACE and ADD1 genes modulate the physiological response to dietary sodium and the activity of the renin-angiotensin-aldosterone system (RAAS), influencing individual blood pressure tendencies.

Clinical and effectiveness evidence

The association between these genotypes and blood pressure regulation is supported by clinical observations and genetic modeling:

• ACE rs4343 GG: This genotype acts as a proxy for the ACE deletion (D) allele. Research involving multiple cohorts confirms that individuals with the GG genotype exhibit significantly higher circulating levels of angiotensin-converting enzyme compared to those with other genotypes ($p < 0.05$).
• Hypertension Risk: Large-scale studies indicate that the ACE rs4343 GG variant is linked to a higher risk of essential hypertension and elevated systolic blood pressure. For example, some data suggest a notable increase in blood pressure response when high ACE activity is combined with specific dietary factors, such as high saturated fat intake ($p = 0.038$).
• ADD1 rs4961 (G460W): The ADD1 variant is a known modulator of renal sodium handling. While the specific GT genotype's contribution is less frequently isolated than the homozygous variants, its involvement in sodium-sensitive blood pressure regulation is established across various ethnic groups.

Mechanistic explanations

The synergy between these variants stems from their dual impact on vasoconstriction and renal sodium retention:

• RAAS Activation: The ACE rs4343 GG genotype leads to increased production of Angiotensin II. As a potent vasoconstrictor and a stimulator of aldosterone secretion, elevated Angiotensin II levels directly drive RAAS-mediated blood pressure elevation and enhance the kidney's drive to retain sodium.
• Renal Sodium Transport: The ADD1 rs4961 polymorphism affects the function of alpha-adducin, a protein that modulates the activity of the Na+/K+-ATPase pump in the renal tubules. Variants in this gene increase the efficiency of sodium reabsorption, leading to volume expansion and increased salt sensitivity.
• Convergent Pathways: When higher RAAS activity (via ACE) coincides with enhanced renal sodium retention (via ADD1), the resulting phenotype is characterized by a strong tendency toward volume-dependent hypertension.

Bottom line

The claim is biologically plausible and supported by genetic associations. The ACE rs4343 GG genotype is a validated marker for high RAAS activity, and when combined with the ADD1 rs4961 variant, it creates a physiological profile prone to salt sensitivity and elevated blood pressure. Individuals with these markers may benefit from targeted salt reduction and RAAS-modulating strategies.